<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-14T16:20:17+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>首个国产PARP抑制剂！恒瑞医药氟唑帕利胶囊今日获批</title>
    <updated>2020-12-14T15:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/hffwuz6h80rd8hppBVKy4A</id>
    <link href="https://mp.weixin.qq.com/s/hffwuz6h80rd8hppBVKy4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方核心行业数据监测周报（12月5-11日）</title>
    <updated>2020-12-14T15:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/NAw-jNQsqpt8VBfcZ22U6A</id>
    <link href="https://mp.weixin.qq.com/s/NAw-jNQsqpt8VBfcZ22U6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康69亿美元收购的DS-8201，临床试验设计有何奥秘？</title>
    <updated>2020-12-14T15:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/hcdSIq_tvpYJMode3m5FdQ</id>
    <link href="https://mp.weixin.qq.com/s/hcdSIq_tvpYJMode3m5FdQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE拟突破性疗法认证：辉瑞JAK3抑制剂，治疗斑秃</title>
    <updated>2020-12-12T14:42:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/-TQYK3vXJ4Q8xvcaYB2Ibw</id>
    <link href="https://mp.weixin.qq.com/s/-TQYK3vXJ4Q8xvcaYB2Ibw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海正药业「海泽麦布片」拟纳入优先审评</title>
    <updated>2020-12-11T18:16:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/jcg68af8rTae2XTl8rvHvA</id>
    <link href="https://mp.weixin.qq.com/s/jcg68af8rTae2XTl8rvHvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>9款仿制药通过一致性评价，东阳光3款</title>
    <updated>2020-12-11T18:16:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/gWEH5n0YauQDsmdAacla5Q</id>
    <link href="https://mp.weixin.qq.com/s/gWEH5n0YauQDsmdAacla5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE拟突破性疗法认证：烨辉医药 ROCK2抑制剂，治疗移植物抗宿主病</title>
    <updated>2020-12-11T18:16:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Zyi1bJqWH_u14XJbYYHw1Q</id>
    <link href="https://mp.weixin.qq.com/s/Zyi1bJqWH_u14XJbYYHw1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE拟突破性疗法认证：合源生物CD19 CAR-T疗法，治疗急性淋巴细胞白血病</title>
    <updated>2020-12-11T18:16:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/t6yGfUd_OlegYesxkmXAfQ</id>
    <link href="https://mp.weixin.qq.com/s/t6yGfUd_OlegYesxkmXAfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华同类首创siRNA降脂药Inclisiran欧盟获批</title>
    <updated>2020-12-11T18:16:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/vi_bgR735wwJ07HUHnzLng</id>
    <link href="https://mp.weixin.qq.com/s/vi_bgR735wwJ07HUHnzLng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来GIP/GLP-1受体双重激动剂III期临床获积极结果</title>
    <updated>2020-12-10T18:23:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/8sr40bVvNf_mcmQjD5PHpA</id>
    <link href="https://mp.weixin.qq.com/s/8sr40bVvNf_mcmQjD5PHpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球肿瘤新药重磅临床进展 | 2020年11月</title>
    <updated>2020-12-10T18:23:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/WRfqUSsJCVic6BI3Of25fQ</id>
    <link href="https://mp.weixin.qq.com/s/WRfqUSsJCVic6BI3Of25fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上交所终止泽生科技科创板IPO</title>
    <updated>2020-12-10T18:23:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/leVZcCW-WFLv7GBiTBzhSQ</id>
    <link href="https://mp.weixin.qq.com/s/leVZcCW-WFLv7GBiTBzhSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进计划于年底向FDA 提交KRAS G12C抑制剂上市申请</title>
    <updated>2020-12-09T18:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Yshb_URfYX0fuu4tuf2eEA</id>
    <link href="https://mp.weixin.qq.com/s/Yshb_URfYX0fuu4tuf2eEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采44个品种相关信息汇总（附清单下载）</title>
    <updated>2020-12-09T18:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/BUinwWlNMWUNuyfDED-RPQ</id>
    <link href="https://mp.weixin.qq.com/s/BUinwWlNMWUNuyfDED-RPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药集团新冠灭活疫苗阿联酋获批上市，保护有效性达86%</title>
    <updated>2020-12-09T18:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/cLtME8NwBFe_KN-0oUAUzw</id>
    <link href="https://mp.weixin.qq.com/s/cLtME8NwBFe_KN-0oUAUzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞「哌柏西利」新剂型申请上市</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/MgnBmvYdSCCoezT9FkJ4Ow</id>
    <link href="https://mp.weixin.qq.com/s/MgnBmvYdSCCoezT9FkJ4Ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月肺癌月报 | 重磅研究、高分综述、新开试验，一文洞悉最新进展！</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/XnbDPtbU9L-r49nvhfZMvg</id>
    <link href="https://mp.weixin.qq.com/s/XnbDPtbU9L-r49nvhfZMvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH2020 | 辉瑞公布CD3双抗治疗多发性骨髓瘤 I 期数据</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/Z6WBsIeiWXxcSy5b59iStw</id>
    <link href="https://mp.weixin.qq.com/s/Z6WBsIeiWXxcSy5b59iStw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生与Xencor达成CD28双抗开发合作</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/0OtUb2ZrvcnA-zeLiPuw_A</id>
    <link href="https://mp.weixin.qq.com/s/0OtUb2ZrvcnA-zeLiPuw_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞干眼病新药NOV03（全氟己基辛烷）获批临床</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/zFDZ-LiiLMNgSBUxJsxdvg</id>
    <link href="https://mp.weixin.qq.com/s/zFDZ-LiiLMNgSBUxJsxdvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>